Authors:
Gomeni, R
Bani, M
D'Angeli, C
Corsi, M
Bye, A
Citation: R. Gomeni et al., Computer-assisted drug development (CADD): an emerging technology for designing first-time-in-man and proof-of-concept studies from preclinical experiments, EUR J PH SC, 13(3), 2001, pp. 261-270
Authors:
Gomeni, R
Teneggi, V
Iavarone, L
Squassante, L
Bye, A
Citation: R. Gomeni et al., Population pharmacokinetic-pharmacodynamic model of craving in an enforcedsmoking cessation population: Indirect response and probabilistic modeling, PHARM RES, 18(4), 2001, pp. 537-543
Citation: Sa. Thomas et al., Transport characteristics of the anti-human immunodeficiency virus nucleoside analog, abacavir, into brain and cerebrospinal fluid, J PHARM EXP, 298(3), 2001, pp. 947-953
Authors:
Cass, LMR
Gunawardena, KA
Macmahon, MM
Bye, A
Citation: Lmr. Cass et al., Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir, RESP MED, 94(2), 2000, pp. 166-173
Citation: C. Brindley et al., Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler (R), Diskus (R) and metered-dose inhaler in healthy volunteers, CLIN PHARMA, 39, 2000, pp. 1-8
Authors:
Mackie, AE
McDowall, JE
Ventresca, P
Bye, A
Falcoz, C
Daley-Yates, PT
Citation: Ae. Mackie et al., Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant, CLIN PHARMA, 39, 2000, pp. 17-22
Authors:
Mackie, AE
McDowall, JE
Falcoz, C
Ventresca, P
Bye, A
Daley-Yates, PT
Citation: Ae. Mackie et al., Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler (R) and Diskus (R) powder devices in healthy volunteers, CLIN PHARMA, 39, 2000, pp. 23-30
Citation: Ae. Mackie et A. Bye, The relationship between systemic exposure to fluticasone propionate and cortisol reduction in healthy male volunteers, CLIN PHARMA, 39, 2000, pp. 47-54
Authors:
Bye, A
Trope, C
Loge, JH
Hjermstad, M
Kaasa, S
Citation: A. Bye et al., Health-related quality of life and occurrence of intestinal side effects after pelvic radiotherapy - Evaluation of long-term effects of diagnosis andtreatment, ACTA ONCOL, 39(2), 2000, pp. 173-180
Authors:
Drusano, GL
D'Argenio, DZ
Preston, SL
Barone, C
Symonds, W
LaFon, S
Rogers, M
Prince, W
Bye, A
Bilello, JA
Citation: Gl. Drusano et al., Use of drug effect interaction modeling with Monte Carlo simulation to examine the impact of dosing interval on the projected antiviral activity of the combination of abacavir and amprenavir, ANTIM AG CH, 44(6), 2000, pp. 1655-1659
Citation: A. Bye et al., Food choice and nutrient intake among patients on a low-fat, low-lactose diet: experience from a prospective randomized study, J HUM NU DI, 12(4), 1999, pp. 273-285
Citation: Lmr. Cass et al., Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers, CLIN PHARMA, 36, 1999, pp. 1-11
Authors:
Cass, LMR
Brown, J
Pickford, M
Fayinka, S
Newman, SP
Johansson, CJ
Bye, A
Citation: Lmr. Cass et al., Pharmacoscintigraphic evaluation of lung deposition of inhaled zanamivir in healthy volunteers, CLIN PHARMA, 36, 1999, pp. 21-31
Authors:
Bergstrom, M
Cass, LMR
Valind, S
Westerberg, G
Lundberg, EL
Gray, S
Bye, A
Langstrom, B
Citation: M. Bergstrom et al., Deposition and disposition of [C-11]zanamivir following administration as an intranasal spray - Evaluation with positron emission tomography, CLIN PHARMA, 36, 1999, pp. 33-39
Citation: A. Bye, Gerhard L''alta naixenca del rei en jaume', 'Sis canconc populars catalanes', 'Cancionero de Pedrell' - Auvidis-montaigne-MO-782106 (Garrigosa, Carmina, Orquestra Sinfonica de Barcelona, Colomer), TEMPO, 207, 1998, pp. 43-44